• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国患者中银屑病严重程度、临床症状、生活质量与工作效率之间的关系。

Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA.

作者信息

Korman N J, Zhao Y, Pike J, Roberts J

机构信息

Clinical Trials Unit, University Hospitals Case Medical Center, Cleveland, OH, USA.

Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.

出版信息

Clin Exp Dermatol. 2016 Jul;41(5):514-21. doi: 10.1111/ced.12841. Epub 2016 Apr 8.

DOI:10.1111/ced.12841
PMID:27061102
Abstract

BACKGROUND

Psoriasis is a chronic disease, and many patients experience itching, painful skin and scaling. The relationship between psoriasis severity and symptom severity, quality of life (QoL) and work productivity is not fully understood.

AIM

To examine how QoL, work productivity and clinical symptoms vary between patients with mild, moderate and severe psoriasis.

METHODS

During a recent US survey, dermatologists provided information on overall disease severity, symptom severity and comorbidities. Patients with psoriasis completed QoL and work productivity instruments: the EuroQoL 5-Dimension Health (EQ-5D) questionnaire, the Dermatology Life Quality Index (DLQI), and the Work Productivity and Activity Impairment (WPAI) questionnaire. Multivariate regression was used to explore the relationship between these outcome variables and psoriasis severity, controlling for differences in demographics and comorbidities.

RESULTS

The study analysed 694 patients (55% male; mean age: 44 years); 48%, 46% and 6% had mild, moderate and severe psoriasis, respectively. Scaling was the most common symptom, which was experienced by 82% of patients, followed by itching (73%) and pain (32%). Increased psoriasis severity was associated with increased itching, pain and scaling, and with reduced QoL (decrease in EQ-5D scores: moderate vs. mild -0.04, severe vs. mild -0.18; increase in DLQI: moderate vs. mild 2.97, severe vs. mild 7.95). WPAI scores increased with severity, indicating greater impairment (moderate vs. mild: 11.77, severe vs. mild 18.73).

CONCLUSIONS

Patients with more severe psoriasis experienced more severe symptoms and had a greater reduction in QoL and work productivity. It is important that physicians recognize the impact of severe disease on patients' lives and take steps to address this.

摘要

背景

银屑病是一种慢性疾病,许多患者会经历瘙痒、皮肤疼痛和脱屑。银屑病严重程度与症状严重程度、生活质量(QoL)和工作效率之间的关系尚未完全明确。

目的

研究轻度、中度和重度银屑病患者的生活质量、工作效率和临床症状如何变化。

方法

在最近一项美国调查中,皮肤科医生提供了关于整体疾病严重程度、症状严重程度和合并症的信息。银屑病患者完成了生活质量和工作效率评估工具:欧洲五维健康量表(EQ-5D)问卷、皮肤病生活质量指数(DLQI)和工作效率与活动障碍问卷(WPAI)。采用多变量回归分析这些结果变量与银屑病严重程度之间的关系,并控制人口统计学和合并症的差异。

结果

该研究分析了694例患者(55%为男性;平均年龄:44岁);分别有48%、46%和6%的患者患有轻度、中度和重度银屑病。脱屑是最常见的症状,82%的患者出现,其次是瘙痒(73%)和疼痛(32%)。银屑病严重程度增加与瘙痒、疼痛和脱屑加剧以及生活质量下降相关(EQ-5D评分下降:中度与轻度相比为-0.04,重度与轻度相比为-0.18;DLQI增加:中度与轻度相比为2.97,重度与轻度相比为7.95)。WPAI评分随严重程度增加,表明损害更大(中度与轻度相比:11.77;重度与轻度相比:18.73)。

结论

银屑病更严重的患者症状更严重,生活质量和工作效率下降幅度更大。医生认识到严重疾病对患者生活的影响并采取措施加以应对很重要。

相似文献

1
Relationship between psoriasis severity, clinical symptoms, quality of life and work productivity among patients in the USA.美国患者中银屑病严重程度、临床症状、生活质量与工作效率之间的关系。
Clin Exp Dermatol. 2016 Jul;41(5):514-21. doi: 10.1111/ced.12841. Epub 2016 Apr 8.
2
Increased severity of itching, pain, and scaling in psoriasis patients is associated with increased disease severity, reduced quality of life, and reduced work productivity.银屑病患者瘙痒、疼痛和脱屑症状的加重与疾病严重程度增加、生活质量下降及工作效率降低相关。
Dermatol Online J. 2015 Oct 16;21(10):13030/qt1x16v3dg.
3
Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions.对当前银屑病治疗的满意度:医生与患者认知之间的差异
Dermatol Online J. 2016 Jul 15;22(7):13030/qt7405k1nn.
4
Impact of psoriasis flare and remission on quality of life and work productivity: a real-world study in the USA.银屑病发作和缓解对生活质量及工作效率的影响:美国的一项真实世界研究
Dermatol Online J. 2016 Jul 15;22(7):13030/qt4vb7q7rr.
5
Pruritus and quality of life in moderate-to-severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study.中重度斑块状银屑病瘙痒和生活质量:来自 PRISTINE 研究的事后探索性分析。
J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1114-20. doi: 10.1111/jdv.12761. Epub 2014 Nov 5.
6
Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry.美国患者银屑病严重程度对患者报告的临床症状、健康相关生活质量和工作生产力的影响:来自 Corrona 银屑病登记处的真实世界数据。
BMJ Open. 2019 Apr 20;9(4):e027535. doi: 10.1136/bmjopen-2018-027535.
7
Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis.司库奇尤单抗与乌司奴单抗治疗银屑病对生活质量、工作生产力和活动障碍的影响差异:结构方程模型分析。
Br J Dermatol. 2018 Jun;178(6):1297-1307. doi: 10.1111/bjd.16366. Epub 2018 Apr 14.
8
Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.中重度银屑病患者使用依那西普治疗后关节疼痛和指甲症状持续改善。
J Eur Acad Dermatol Venereol. 2009 Aug;23(8):896-904. doi: 10.1111/j.1468-3083.2009.03211.x. Epub 2009 May 3.
9
Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.从皮肤病生活质量指数生成 EQ-5D-3L 效用评分:一项针对银屑病患者的映射研究。
Value Health. 2018 Aug;21(8):1010-1018. doi: 10.1016/j.jval.2017.10.024. Epub 2017 Dec 26.
10
The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis.阿达木单抗治疗对中重度银屑病患者自我报告的工作生产力和活动障碍的影响及银屑病严重程度的影响。
J Am Acad Dermatol. 2012 Feb;66(2):e67-76. doi: 10.1016/j.jaad.2010.10.020. Epub 2011 May 25.

引用本文的文献

1
Analysis of the Reduction in the Duration of Sick Leave for 32,512 Psoriasis Patients Following the Integration of Targeted Therapies for Psoriatic Disease into the Brazilian Healthcare System: a Retrospective Cohort Study.针对32512名银屑病患者,在巴西医疗体系中纳入银屑病靶向治疗后病假时长缩短情况的分析:一项回顾性队列研究。
Psoriasis (Auckl). 2025 Mar 28;15:105-116. doi: 10.2147/PTT.S513878. eCollection 2025.
2
Patient Disease Characteristics and Treatment Patterns in Mild-Moderate Psoriasis: Results from Real-World Clinical Practice in the United States (PROSPECT Study).轻度至中度银屑病患者的疾病特征与治疗模式:美国真实世界临床实践结果(PROSPECT研究)
Dermatol Ther (Heidelb). 2025 Mar;15(3):663-680. doi: 10.1007/s13555-025-01353-x. Epub 2025 Feb 17.
3
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis.古塞库单抗对中度至重度斑块状银屑病患者焦虑、抑郁及生活质量的直接和间接影响:一项中介分析
Dermatol Ther (Heidelb). 2024 Sep;14(9):2577-2589. doi: 10.1007/s13555-024-01250-9. Epub 2024 Aug 23.
4
Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey.评估美国中重度银屑病患者的治疗选择:一项美国患者调查的结果
Dermatol Ther (Heidelb). 2024 Feb;14(2):421-439. doi: 10.1007/s13555-023-01089-6. Epub 2024 Jan 22.
5
Unmet needs in the management of psoriasis in Latin America: a systematic review.拉丁美洲银屑病管理中的未满足需求:系统评价。
An Bras Dermatol. 2024 Mar-Apr;99(2):244-258. doi: 10.1016/j.abd.2023.04.006. Epub 2023 Dec 6.
6
Tapinarof cream 1% once daily for the treatment of adults with mild to severe plaque psoriasis: A novel topical therapy targeting the aryl hydrocarbon receptor.他卡西醇乳膏 1%每日一次治疗成人轻至重度斑块状银屑病:一种针对芳烃受体的新型局部治疗药物。
J Manag Care Spec Pharm. 2023 Dec;29(12-a Suppl):S1-S13. doi: 10.18553/jmcp.2023.29.12-a.s1.
7
Metabolic Disorders and Psoriasis: Exploring the Role of Nutritional Interventions.代谢紊乱与银屑病:营养干预作用的探索
Nutrients. 2023 Sep 6;15(18):3876. doi: 10.3390/nu15183876.
8
Impact of Season and Other Factors on Initiation, Discontinuation, and Switching of Systemic Drug Therapy in Patients with Psoriasis: A Retrospective Study.季节及其他因素对银屑病患者全身药物治疗起始、停药及换药的影响:一项回顾性研究
JID Innov. 2022 Nov 17;3(2):100171. doi: 10.1016/j.xjidi.2022.100171. eCollection 2023 Mar.
9
Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study).基于真实世界数据使用特诺雅治疗患者的报告健康状况:一项多国、四期、单队列前瞻性观察研究(POSITIVE 研究)方案。
BMJ Open. 2023 Feb 15;13(2):e060536. doi: 10.1136/bmjopen-2021-060536.
10
A Cross-Sectional Study on the Relationship Between Rosacea Severity and Quality of Life or Psychological State.一项关于酒渣鼻严重程度与生活质量或心理状态之间关系的横断面研究。
Clin Cosmet Investig Dermatol. 2022 Dec 20;15:2807-2816. doi: 10.2147/CCID.S390921. eCollection 2022.